Hereditary Genetics Syndromes Flashcards
Which cancers have genetic linkages?
- colorectal cancer
- prostate cancer
- pancreatic cancer
- ovarian cancer
- breast cancer
- malignant melanoma
What is the most common cancer in women worldwide?
breast cancer
What is the second most deadly cancer after lung cancer?
breast cancer
What is the lifetime risk for breast cancer?
10-13%
What percentage of breast and ovarian cancer are attributed to genetics?
only 5-10%
What are risks as predictors of breast cancer?
- age
- gender
- family history
Hereditary breast cancer is caused by?
pathogenic variant of either BRCA1 or BCRA2
Hereditary breast cancer has what type of inheritance pattern?
autosomal dominant with high penetrance
Who can carry pathogenic variants in BCRA1 and BRCA2?
Men and women
Increased risks of hereditary breast cancer due to what in certain groups?
founder effect
BRCA1 and BRCA2 mutations are more prevalent in which population?
Ashkenazi Jews
Who do you have to review when you have an Ashkenazi Jew who has hereditary breast cancer?
- review both sides of the family
- if either one first-degree relative has been diagnosed with breast cancer OR two second-degree relatives
- consider genetic counseling
What genes are tumor suppressor genes that:
- control cell growth and death
- repair damaged DNA/preserve chromatid structure
- genomic stability
- transcription regulation
- cell cycle control
BRCA1 and BRCA2
Increased translocations, inversions, deletions, and fusions of non-homologous chromosomes is consistent with what?
cells with abnormal or deficient BRCA1/2
What types of cancers are associated with BRCA1 and BRCA2 mutations?
- breast cancer (male and female)
- ovarian, fallopian, or primary peritoneal
- pancreatic
- prostate
Which BRCA mutation is associated with a higher lifetime risk of cancer?
BRCA 1
In male breast cancer, the BRCA2 mutation increases lifetime risk to what?
2-7% (from 0.1%)
The main age of diagnosis of cancer is younger with which BRCA mutation?
BRCA1
Men with HBOC has an increased susceptibility to what?
- breast cancer
- skin cancer
- prostate
Men with HBOC have a higher risk with which BRCA mutation?
BRCA 2
What should you suspect with any of the following:
-onset of breast cancer prior to 50
-breast cancer at any age with Ashkenazi Jewish ancestry
-multiple primary breast cancers in one or both breasts
-two or more relatives with breast cancer, one diagnosed at or before age 50
-three or more breast cancer relatives
-male breast cancer
-“triple negative” receptor breast cancer
-ovarian cancer
-pancreatic or prostate cancer combined with breast or ovarian cancer in family/individual
-known familial mutation of HBOC
HBOC
What is the 2nd most common gynecologic malignancy?
ovarian cancer
What is the main common cause of gynecologic cancer death?
ovarian cancer
Approximately what percent of ovarian cancers are related to HBOC?
20%
Women with what mutations have more multifocal disease and more aggressive tumors for ovarian cancer?
BRCA 1 and BRCA 2 mutations
What are these common symptoms associated with?
-feeling full quickly after starting to eat
-pain in pelvis or abdomen
-bloating
-more urgent or frequent urination
ovarian cancer
Who should you test for HBOC mutations?
women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry associated with BRCA1/2 gene mutations
Who should you not recommend to get tested for HBOC mutations?
women whose personal or family history is not associated with potential harmful BRCA1/2 gene mutations
What are some risk assessment tools for HBOC?
- gail model 2 (used in practice and research; not appropriate with BRCA mutations)
- breast and ovarian analysis of disease incidence and carrier estimation algorithm (used to calculate specific HBOC risk, primarily used in research)
What does an ambiguous genetic test result for HBOC mean?
mutation in either BRCA1 or BRCA 2 that has uncertain link to HBOC
Management of HBOC breast cancer in women with BRCA 1/2 mutations should consist of what?
age 25:
- clinical exam every 6-12 months
age 25-29:
- annual mri with contrast or mammogram
age 30-75:
- annual mammogram and mri with contrast
age >75:
- considered on individual basis
discuss option of risk-reducing mastectomy, consider risk reducing agents
Management of HBOC breast cancer in males with BRCA1/2 mutations should consist of what?
age 35:
- self exam training and education
- clinical breast exam, every 12 months
Management of HBOC ovarian cancer with BRCA 1/2 mutations should consist of what?
- risk reducing salpingo-oophrectomy
- age 35-40, upon completion of child bearing
- RRSO could be delayed in BRCA2 carriers until age 40-45 because of later age onset
- consider risk reducing agents
- transvaginal ultrasound and CA-125 maybe at the clinicians discretion
Management of HBOC prostate cancer with BRCA 1/2 mutations should consist of what?
age 45:
- recommended screening for BRCA2 carriers
- consider screening for BRCA1 carriers